Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 121.97 is 184% above its 5-year average of 42.94, near the high end of its 5-year range (7.69–126.15).
As of the fiscal period ended Tuesday, June 30, 2026. 59.03% above its 12-month average of 76.70.
Reported quarterly current ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 121.97.
CURRENT RATIO
121.97
CURRENT RATIO AVG TTM
76.70
CURRENT RATIO AVG 3Y
53.53
CURRENT RATIO AVG 5Y
42.94
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+59.03%
CURRENT VS 3Y AVG
+127.86%
CURRENT VS 5Y AVG
+184.06%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+3152.61%
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$472.23M
Current Ratio
121.97
TTM Avg
76.70
3Y Avg
53.53
5Y Avg
42.94
Market Cap
$475.91M
Current Ratio
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$483.54M
Current Ratio
2.91
TTM Avg
1.77
3Y Avg
1.71
5Y Avg
1.57
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $472.23M | 121.97 | 76.70 | 53.53 | 42.94 |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 7.91 | 4.78 | 4.69 | 6.49 |
| Cerus Corporation (CERS)vs › | $471.57M | 1.83 | 2.06 | 1.93 | 2.19 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | 4.49 | 4.20 | 4.79 | 6.06 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 37.17 | 24.09 | 19.47 | 19.38 |
| Kamada Ltd. (KMDA)vs › | $467.90M | 4.06 | 3.90 | 3.27 | 3.77 |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | 4.95 | 9.63 | 11.08 | 12.07 |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 2.91 | 1.77 | 1.71 | 1.57 |
| Evolus, Inc. (EOLS)vs › | $486.01M | 1.70 | 2.15 | 2.20 | 2.10 |
| NRC Health (NRC)vs › | $452.54M | 0.65 | 0.55 | 0.77 | 1.10 |
Current Ratio
121.97
Quick Ratio
121.97
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 121.97 |
| 2026-03-31 | 81.48 |
| 2025-12-31 | 57.37 |
| 2025-09-30 | 36.10 |
| 2025-06-30 | 86.56 |
| 2025-03-31 | 88.27 |
| 2024-12-31 | 126.15 |
| 2024-09-30 | 11.32 |
| 2024-06-30 | 35.08 |
| 2024-03-31 | 7.69 |
| 2023-12-31 | 8.01 |
| 2023-09-30 | 24.26 |
| 2023-06-30 | 11.62 |
| 2023-03-31 | 9.83 |
| 2022-12-31 | 21.64 |
| 2022-09-30 | 8.11 |
| 2022-06-30 | 22.88 |
| 2022-03-31 | 11.72 |
| 2021-12-31 | 31.48 |
| 2021-09-30 | 31.38 |
| 2021-06-30 | 68.80 |
| 2021-03-31 | 62.90 |
| 2020-12-31 | 22.87 |
| 2020-09-30 | 5.82 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
